| Tag | Content |
|---|
EnhancerAtlas ID | HS098-28288 | Organism | Homo sapiens | Tissue/cell | HSMM | Coordinate | chr19:48626660-48627940 | | | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_38541 | chr19:48623752-48630434 | HUVEC |
| | | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
| | | Number: 1 | ID | Chromosome | Start | End |
| GH19I048121 | chr19 | 48624402 | 48628169 |
| Enhancer Sequence | GTGCGGGTCA CAACTAGTGA CAGGGTTCGT GGAAAGCCTT GAGAGGGAAG AACCCTGATG 60
TCAGAAGGAT TCTGAGAGCT TAAAGCATGG GGCTAGTCAC TGGCAAGAGG GCCCGACACC 120
ATTTAGAGTC GGTGACTTCA GGAGCATCAG ACGGGGGGCT GCGGCCTTGC TGGAGCTTGA 180
ATTAACACTT TACGGGCATC TCATCAGTTT TGTTTTTTGT TTTTGTTTTT TTGAGACGGA 240
ATCTCGCTCT GTCGCCCAGG CTGGAGTGCG GTGGTGCGAT CTTGGCTGAC TGCAGCCTCC 300
GCCTCCTGAA TTCAAGCGAC TGTCTTGCGT CGGCCTCCCG AGTAGCTGGG ACTACAGGTG 360
CACATCACAA GAGATCCACC CACCTCAGCC TCCCAAAGTG TTGGGATTAC AGGCGTGAGC 420
CACTGCATCC AGCCTCATCC CCAAGATAAT TAAAAAAAAA AAAAAAAGTC CTCCTTTCCT 480
TAGAATTCCA AAAGTTTTCA CTGAGTTTTT CCAGCACATT TACAGTTTTG TGTTTTGCTT 540
TGAAATCAGT TCCAGCTGGA CCTTGCAAGA GTGTGTGTCA GAGAGGAAGG AGGTGATCTG 600
AGTGTTTTTA AACAAAGGAC AAAGCAGTTG TCTCCACATG TCAACACTGA CTAATCCGTC 660
TTGTGGCTTT GAATTGCTTT TCTCTTTTGT TCGATCGGTC CCCACCCACG CGCAGTGTTT 720
CTGGTCTGCC CTTTGCTCAG GGCTTCTCTG TGATGATGTT AAACTACCTT CACCACTTGC 780
CCTCCAGGGG GACATTCACG TGTTTTCCAT GGACAGCTTT TTTCTGTTGT AAAATTGTGC 840
TCATGAACAT TTTGTATGAA AAGATGAGAG AGAGGAGCCA CAAGGGTTAA GCAGGTACAA 900
TTTATCTGGG GTCAGACCAT TTCAGGTTTA CATCCCAGCC ACACGCTTCC TAGCTGGTGA 960
CTTCAGGCAA GCGTTTCCCT CTGTGTACCT CAGAGCTCCC ATCTGTAAAA TGCAGCAATA 1020
CCTACTCAGG GCACGTCTGG GAAGATCAGC TGAGCCCGTG CTACCCAGTG TAGCCGCCAC 1080
CAGCCATGTG TAGCAATTGA GCCCTTGAAA TGTAGCAAGT TCAATCGGAG ATGTGCCAAG 1140
GGCAAAACAG TCACTGGCTT TAGAAGACTT AATCCAAGAA AAGAGTGTAA AATTCCATGT 1200
TAATAATTTC TTATATTCAT CACACATTGA AAGGATAATA TCTTAGACAT TGGATTAAAG 1260
AAAATATGAT TTTATCTGTT 1280
|
| |
|
|
|
